{
  "ticker": "JNJ",
  "target_date": "2025-09-24",
  "actual_date": "2025-09-24",
  "collected_at": "2025-12-08T12:19:11.859904",
  "price": {
    "open": 175.03,
    "high": 175.83,
    "low": 174.63,
    "close": 175.5752410888672,
    "volume": 6676800,
    "change_1d_pct": 0.06,
    "change_7d_pct": -0.4,
    "change_30d_pct": 3.01
  },
  "technicals": {
    "rsi_14": 44.25,
    "sma_20": 175.83,
    "sma_50": 171.77,
    "macd": 0.87,
    "macd_signal": 1.456,
    "macd_histogram": -0.585,
    "bb_upper": 178.46,
    "bb_lower": 173.21,
    "price_vs_sma20_pct": -0.15,
    "price_vs_sma50_pct": 2.22,
    "volume_ratio": 0.82
  },
  "fundamentals": {
    "market_cap": 487400407040,
    "pe_ratio": 19.527027,
    "forward_pe": 19.084906,
    "price_to_book": 6.140165,
    "price_to_sales": 5.289264,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.65,
    "pct_from_52w_low": 43.8
  },
  "macro": {
    "spy": {
      "price": 661.1,
      "change_1d_pct": -0.32,
      "change_7d_pct": 0.44
    },
    "vix": {
      "level": 16.18,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.15
    },
    "dollar_index": {
      "level": 97.87
    },
    "gold": {
      "price": 3732.1
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Why This Dividend King Still Stands Tall",
      "source": "Yahoo",
      "datetime": 1758756602,
      "summary": "With a strong product portfolio and growth prospects in innovative medicines, this dividend stock is likely to maintain its 63-year streak of dividend increases.",
      "url": "https://finnhub.io/api/news?id=5973ed96ae023ab278b751398deee78fc78bf839eeed69bd26e65f1bea8842d8"
    },
    {
      "headline": "Takeda: Excellent Pipeline Kaizen - 6 Drugs, $20 Billion Annually",
      "source": "SeekingAlpha",
      "datetime": 1758735634,
      "summary": "Takeda offers a compelling investment case with six late-stage therapies targeting $20 billion in peak sales by 2030-31. Click to read why TAK is a Strong Buy.",
      "url": "https://finnhub.io/api/news?id=7ecb21fb8423fde87617c6680b90e9f8522d8dbd7307e733cd3cdfce246117e3"
    },
    {
      "headline": "Johnson & Johnson (JNJ) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript",
      "source": "SeekingAlpha",
      "datetime": 1758734261,
      "summary": "Johnson & Johnson (NYSE:JNJ) Bernstein 2nd Annual Global Healthcare Conference September 24, 2025 1:10 PM EDTCompany ParticipantsTom Cavanaugh - Company...",
      "url": "https://finnhub.io/api/news?id=a409551f4e4f435a37ac964f212893399b06928f3fc2f4985a15eba796e585ca"
    },
    {
      "headline": "As Trump Takes Aim at Tylenol, Should You Buy, Sell, or Hold Parent Company Kenvue Stock\u2019s Here?",
      "source": "Yahoo",
      "datetime": 1758733927,
      "summary": "Kenvue stock is trailing the broader markets by a wide margin in 2025 due to regulatory concerns over its flagship Tylenol product.",
      "url": "https://finnhub.io/api/news?id=cca9dce5b6c09067b1ee76bcb9bc3e5bc30d00c5332230a585e94beab7fa1c69"
    },
    {
      "headline": "Best Dividend Kings: September 2025",
      "source": "SeekingAlpha",
      "datetime": 1758728950,
      "summary": "Discover which Dividend Kings outperformed the SPY in 2024, top stock picks, growth outlooks, and find undervalued opportunities.",
      "url": "https://finnhub.io/api/news?id=3e6cbbdf3db3c5e8c25ad1d3ffcb9866ab9fe4541eb1d96cdb1b4444696daa1f"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627547.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000196/xslF345X05/wk-form4_1757627547.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627315.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000194/xslF345X05/wk-form4_1757627315.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627206.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000192/xslF345X05/wk-form4_1757627206.xml"
    },
    {
      "form": "8-K",
      "date": "2025-09-09",
      "description": "jnj-20250908.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000190/jnj-20250908.htm"
    },
    {
      "form": "4",
      "date": "2025-09-05",
      "description": "xslF345X05/wk-form4_1757109644.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000186/xslF345X05/wk-form4_1757109644.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}